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Abstract
Impaired microcirculation secondary to underlying vascular endothelial dysfunction is
increasingly recognized to play a central role in the pathophysiology associated with
numerous postoperative complications. Noxious stimuli, including direct injury from
surgical trauma and hypoxia (e.g.,  ischemia‐reperfusion injury), trigger adrenergic‐
inflammatory‐thrombotic‐immune  cascades  to  impair  the  microcirculation,  with
consequent perfusion‐related postoperative complications. The endothelium, charac‐
terized by exquisite sensitivity to inflammation and low proliferative potential, has
limited self‐repair  capacity  that  is  dependent  on circulating  bone marrow‐derived
endothelial progenitor cells for regeneration. As such, the extent to which the endothe‐
lial  physical  and  functional  integrity  is  preserved  mirrors  not  only  underlying
cardiovascular health but is also an important factor in susceptibility to postoperative
morbidity.  This  review  explores  the  effect  of  perioperative  inflammation  on  the
microcirculation and some of the current protective strategies available to clinicians.
“Prehabilitation,” with preoperative exercise to improve the underlying endothelial
function and bone marrow responsiveness for endogenous endothelial repair mecha‐
nisms, and anti‐inflammatory strategies to limit activation of the endothelial‐throm‐
botic‐inflammatory  cascades  may  provide  clinical  strategies  to  preserve  the
microcirculation to engender optimal surgical outcomes.
Keywords: microcirculation, endothelial dysfunction, inflammation, perioperative,
surgery
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1. Introduction
With an estimated 234 million operations performed annually, surgical care is an integral part
of health care throughout the world [1]. Furthermore, the World Health Organization (WHO)
estimates that the incidence of trauma, predominantly requiring surgery, accounts for 10% of
deaths and 16% of disabilities worldwide—considerably more than malaria, tuberculosis, and
HIV/AIDS combined [2].
Confounding the underlying comorbidities that patients present with during surgery, patients
also suffer a significant biologic perturbation—the “surgical stress response”—a significant
stressor to the human body during the perioperative period. A variety of systems are involved
in this stress response, including the sympathetic autonomic nervous system, endocrine
system, and immune system [3]. Inflammatory mechanisms are intimately tied to the immune
system and contribute to direct defense against infection and promote postoperative wound
healing. This physiological reaction of the human body can be exaggerated by a systemic
inflammatory response syndrome (SIRS) [4]. SIRS results from the release of endogenous
factors such as damage‐associated molecular patterns (DAMPs) or alarmins [4, 5] after surgical
tissue injury [6]. DAMPs activate the complement system, leading to a rapid generation of C3a
and C5a [7–9] and initiation of the release of a myriad of inflammatory mediators such as
adiponectin, leptin, C‐reactive protein, interleukins (IL‐8, IL‐10, etc.), soluble tumor necrosis
factor‐receptor 1(sTNF‐R1), and 8‐isoprostane.
Figure 1. The surgical pro‐inflammatory and pro‐oxidant milieu may result in both functional and structural altera‐
tions in the endothelium, resulting in hemostatic dysregulation and impaired microcirculation with consequent micro‐
vascular‐related postoperative complications (Illustration courtesy of Dr Marissa Ferguson).
Interestingly, these inflammatory mediators, described as a systemic “inflammome,” are
increased in obese patients presenting for bariatric surgery [10]. Hence, this suggests that a
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significant number of patients may present to surgery with an underlying pro‐inflammatory
state and is also seen in patients with inflammatory comorbidities, such as rheumatoid disease,
inflammatory bowel disease, and diabetes mellitus [11, 12]. This inflammatory burden
activates cellular processes at affected sites within tissues, with enhanced capillary permea‐
bility to soluble mediators, particles, and cellular trafficking. These systems are in a delicate
balance, which can be easily disrupted to exacerbate disease or organ dysfunction [13].
Impaired microcirculation, largely driven by vascular endothelial dysfunction, is increasingly
implicated as a central pathophysiological feature of postoperative morbidity. Microcircula‐
tion is affected by certain noxious stimuli, many of which are common to the perioperative
period, including direct injury from surgical manipulation or hemodynamic shear stress,
hypoxia (e.g., ischemia‐reperfusion injury), and through exposure to inflammatory cytokines
and endotoxins. Perioperative inflammation caused in reaction to surgical trauma causes a
pro‐inflammatory and pro‐oxidant milieu that results in both functional and structural
alterations in the endothelium. This may lead to microcirculation hemostatic dysregulation
with impaired local tissue perfusion and consequent micro‐ and macrovascular‐related
postoperative complications (Figure 1) [14, 15].
2. Physiology of the endothelium
The endothelial “organ” is estimated to weigh approximately 1 kg in adults and covers the
entire vasculature with a single layer of cells, covering a surface area of approximately 100–
150 m2 and comprising 10–60 trillion cells in a single layer.
For a long time, the endothelium was considered to be inert, tasked with passive maintenance
of a non‐thrombogenic blood‐tissue interface. In 1980, however, Furchgott and Zawadzki [16]
discovered the endothelium‐derived relaxing factor (nitric oxide), and since then our under‐
standing of the importance of the vascular endothelium has undergone a dramatic evolution.
The endothelium is now recognized as a complex tissue composed of key immunoreactive
cells that respond to environmental conditions. Sandwiched between the blood compartment
and the vascular smooth muscle cells, the single layered endothelium is ideally located to act
as a dynamic sensor‐effector organ. Most of the endothelial cell mass is found in the endothelial
lining of the resistance vessels and capillaries, thereby exposing a relatively large endothelial
surface to a small volume of blood (up to 5000 cm2/ml). This facilitates the exchange of nutrients
and metabolic products [17], and thus allows the endothelium to exert significant autocrine,
paracrine, and endocrine actions on smooth muscle cells, platelets, and peripheral leukocytes.
Endothelial cells, thereby, participate actively and reactively in the regulation of a number of
key physiological processes, including vascular tone, vascular permeability, hemostasis
(thrombosis, fibrinolysis, and platelet adherence), immune and inflammatory (leukocyte
adherence) reactions, angiogenesis, and maintenance of the basement membrane. This
dynamic “gate keeping” role of the endothelium, modulated through its metabolic and
synthetic functions (such as production of nitric oxide, endothelin, prostaglandins, cytokines,
growth factors, and adhesion molecules) and through the expression of endothelial cell
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receptors and glycoproteins on the abluminal surface, allows the healthy endothelium to
maintain a dominant state of vasodilation, anti‐thrombosis/pro‐fibrinolysis by inhibition of
platelet and leukocyte adhesion—a state that is indispensable for body homeostasis [18].
3. Pathophysiology of the endothelium
In contrast, endothelial dysfunction, activation, and injury are characterized by inhibition of
vasodilation, promotion of a pro‐thrombotic/anti‐fibrinolytic state, and promotion of platelet
and leukocyte adhesion. Altered release of endothelium‐derived factors appears to be pivotal
in pathophysiological changes that occur in disease states, such as atherosclerosis, thrombosis,
hypertension, pulmonary hypertension, eclampsia, hyperglycemia, diabetes, metastatic
disease, immune diseases, inflammatory syndromes, infectious processes, and sepsis. Indeed,
there is increasing evidence that perturbations in the vascular endothelium are directly or
indirectly involved in the pathophysiology of numerous disease processes, including postop‐
erative morbid events.
Figure 2. The phenotypic expression of the endothelium can be described as a dynamic “set point” that ranges be‐
tween a quiescent, activated, or dysfunctional state. Endothelial cell (EC) dysfunction caused by perioperative inflam‐
mation in response to an acute stressor (surgery, critical illness) is accompanied by microcirculatory hypoperfusion
that can lead to end‐organ dysfunction.
The crucial step in the progression of perioperative endothelial dysfunction is the change of
the endothelium from a quiescent into an active state. The endothelium, activated by exposure
to inflammatory cytokines, becomes prothrombotic, prone to vasoconstriction instead of
vasodilation, and more porous with increased fluid extravasation and increased cellular
trafficking to the intercellular space. A systemic response to major trauma, associated with a
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lowered ability to fight infection and susceptibility to sepsis, will further activate the destruc‐
tive inflammatory response [19].
In those patients presenting with underlying impaired preoperative microcirculatory function
now confounded by the pathophysiologic changes to the endothelium that accompanies the
surgical stress response will be at higher risk of deterioration of the endothelial reserve below
a critical “physiologic threshold” required to sustain microvascular integrity and perfusion
(Figure 2).
4. Endothelial regeneration
Through reconstitution of the endothelial layer, which generally occurs in the presence of
angiogenesis and vasculogenesis, endothelial function can be restored. Neovascularization is
mediated through migration and proliferation of endothelial cells within the vasculature.
Endothelial colony‐forming cells (CFCs) developing endothelial progeny is the key factor in
order for mature endothelial cells to proliferate and restore endothelial function [20–22]. For
adult vasculogenesis, endothelial progenitor cells (EPCs) play an important role for the de novo
formation of blood vessels. Historically, the presence of circulating blood cells with the ability
to promote vascular repair and regeneration was first described in 1997 [23]. A variety of
seemingly endothelial‐specific cell surface antigens were displayed on the cells identified as
EPCs. Subsequently, numerous experimental studies have assessed the mechanism induced
by tissue ischemia, vascular trauma, tumor growth, and inflammation by which EPC are
released from the bone marrow, travel to the sites of active neovascularization, and initiate the
homing process in the endothelial layer. Furthermore, some studies suggest EPCs as a
biomarker for clinical disorders, such as cardiovascular disease [24], cerebrovascular disease
[25, 26], sepsis [27], and numerous types of cancer [28, 29]. Interestingly, there is an inverse
correlation between the number of bonemarrow released, circulating EPC and the postoper‐
ative complication risk. Subsequent experimental data from marrow transplantation demon‐
strated that these stem cells are recruited to sites of active neovascularization and differentiate
into vascular cells in‐situ. However, the frequency of this occurrence and the identification of
the cell type involved need to be fully determined [30].
5. Endothelial progenitor cell populations
A major limitation in this field has been the lack of specific markers and different methods
used to identify circulating EPCs. Different methods included flow cytometry, cell culture
methods, immunostaining, and consequently render comparison difficult. Three functional
populations of EPCs have generally been well defined. A cellular population that expresses
the phenotype CD34+ AC133+ KDR+ has gained wide acceptance as a measure of circulating
EPC in human subjects [31]. These cells, while being recruited to denuded vessels in ischemic
sites, do not become persistent vascular endothelial cells or display de novo in‐vivo vasculo‐
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genic potential, but rather exhibit potent paracrine properties to regulate new vessel formation
through angiogenesis [32, 33]. These cells are referred to as proangiogenic hematopoietic cells
[22, 34, 35]. Colony‐forming assays, in which plated human CD34+ peripheral blood cells form
cellular clusters on fibronectin‐coated dishes in‐vitro, have identified other populations of
EPC. Asahara et al. [23] described that CD34+ peripheral blood cells form clusters, bind
acetylated low‐density protein (acLDL) and differentiate into spindle‐shaped endothelial cells.
These cell clusters are referred to as EPC colony‐forming units (CFU). A third population of
EPCs, identified as yet another type of cell colony emerging from plated peripheral blood
mononuclear cells, form tightly adherent cells with a cobblestone appearance and are referred
to as endothelial colony‐forming cells (ECFC), late outgrowth cells (OEC), or blood outgrowth
endothelial cells (BOEC). These cells become part of the systemic circulation of the host and
have vessel‐forming ability [36] These ECFCs, with in vivo human vessel‐forming ability,
exhibit the greatest features consistent with human postnatal vasculogenic cells [37].
EPC enumeration correlates with cardiovascular risk factors, extent of coronary disease, and
risk of future cardiovascular events [24]. EPC enumeration and functional characterization
assess the reparative ability and propensity to cardiovascular injury, and thus greatly improves
the risk stratification of patients for postoperative morbidity. Given that peripherally circulat‐
ing EPCs and intrinsic stem cells play an important role in accelerating endothelialization and
tissue remodeling following vascular damage from both disease and toxic insults, we antici‐
pate that therapeutic attempts to stimulate mobilization and homing of bone marrow‐derived
EPC or exogenous administration of cell‐based (progenitor) therapies will likely emerge in
clinical medicine over the next decade [38–40]. Comorbid disease states and aging associate
with decreased regenerative ability by EPCs and may underlie the etiology of postoperative
complications and delayed recovery following surgery. For example, diabetes is characterized
by poor bone marrow mobilization and decreased proliferation and survival of EPCs [41].
Inhibiting oxidative stress has been shown to modulate EPCs and normalize post‐ischemic
neovascularization in diabetics. Similarly, EPC mobilization is also reported to improve with
insulin therapy in diabetic rats [42]. Whether this effect is mediated by insulin itself or through
improved glucose control needs to be clarified.
6. Impaired endothelium‐dependent vascular function in the clinical
setting
An intact microcirculation is key for the functional success of the cardiovascular system and
end‐organ perfusion. In the perioperative period, a wide range of microcirculatory alterations
associated with surgery itself, including factors such as anesthesia type, hypothermia,
hemodilution, inflammatory reaction, and microemboli formation [43,44], impair endotheli‐
um‐dependent vascular function to decrease blood flow and oxygen supply to the parenchy‐
mal cells. An improved understanding of the different types of microcirculatory alterations
may also contribute to reducing perioperative complications. Variants of impaired microcir‐
culation include impaired microcirculatory perfusion where obstructed capillaries are
observed next to capillaries with flow, often seen in clinical conditions such as sepsis or
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reperfusion injury; microcirculatory alterations characterized by increased diffusion distance
between oxygen‐carrying red blood cells and tissue cells, often seen in hemodilution that
accompanies cardiopulmonary bypass; microcirculatory tamponade, often associated with
excessive use of vasopressors and/or increased venous pressure. This fluid overload causes
tissue edema that consequently leads to a damage of endothelial cells and losses of hemody‐
namic coherence, glycocalyx barriers, and/or the compromise of adherence and tight junc‐
tions [45].
7. Impaired microcirculation during critical illness
Alterations of the cerebral microcirculation may represent a key component for the develop‐
ment of postoperative sepsis‐associated encephalopathy. Cerebral hypoperfusion is a common
complication of sepsis and its pathophysiology is complex and related to numerous processes
and pathways, while the exact mechanisms producing neurological impairment such as
delirium in septic patients is not fully understood. Cerebral hypoperfusion is caused by
vasoconstriction that may be induced by inflammation and hypocapnia. The underlying
endothelial dysfunction in sepsis leads to impairment of microcirculation and cerebral
metabolic uncoupling that may further reduce brain perfusion. The natural autoregulatory
mechanisms that protect the brain from reduced/inadequate cerebral perfusion can be
impaired in septic patients, especially in those with shock or delirium, and this further
contributes to cerebral ischemia if blood pressure drops below critical thresholds [46].
Postoperative brain dysfunction (delirium and coma) may relate to impaired microcirculation
following surgical trauma and the associated inflammation seen in the postoperative period.
Postoperative neurocognitive dysfunction is very prevalent, especially in the elderly surgical
patient population. It has been reported to independently associate with prolonged mechanical
ventilation, longer and more costly hospitalizations, delayed cognitive dysfunction that
persists for months after hospital discharge, and increased mortality [47–53]. Factors impli‐
cated in the pathogenesis of acute brain dysfunction, such as inflammation, abnormal cerebral
blood flow, and increased blood‐brain barrier permeability [54, 55], are known to impact
endothelial function. Similarly, critical illnesses, such as sepsis and multiple organ dysfunction
syndrome, states that circulating inflammatory cytokines affect endothelial nitric oxide
production and expression of adhesion molecules [56, 57]. This results in coagulation system
activation, altered perfusion, distorted permeability, and decreased ability for vascular repair
[58, 59]. In the brain specifically, structural and functional alterations of blood–brain barrier
endothelial cells secondary to inflammatory states have been associated with increased
microvascular permeability and impaired microcirculatory blood flow [60–63]. This relation‐
ship between endothelial dysfunction and brain dysfunction during critical illness is increas‐
ingly reported in critically ill patients. The observed impact of endothelial dysfunction and
injury on brain function will also likely reflect that seen in other end organs, including acute
lung injury following surgery [64] or during critical illness [65].
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8. Therapeutic options to improve perioperative endothelial dysfunction
Therapeutic modulation of underlying subclinical microvascular endothelial dysfunction
holds promise for a significant reduction in perioperative morbidity and specifically for
complications such as impaired wound healing and end‐organ dysfunction related to impaired
microcirculation following surgery. Perioperative inflammation can be targeted with non‐
steroidal anti‐inflammatory drugs to limit activation of the endothelial‐thrombotic‐inflamma‐
tory cascades with potential to improve perioperative outcomes [66–68]. Other therapeutic
interventions, including preoperative exercise capacity, which aim to improve endothelial‐
dependent vascular function before surgery in order to cope with the inflammatory burden
are currently under investigation in clinical studies [69, 70].
9. Mobilizing of endothelial progenitor cells with preoperative exercise
Numerous factors have an important role in the mobilization of EPCs [71, 72]. These include
growth factors (e.g., GM‐CSF, GCSF, VEGF, placental growth factor, erythropoietin, and
angiopoietin‐1), pro‐inflammatory cytokines, chemokines (e.g., stromal cell‐derived factor‐1),
hormones (e.g., estrogens, and lipid lowering and antidiabetic drugs), and physical activity
[73]. The stimulatory effect of exercise on EPC has been shown in highly trained athletes [74],
healthy subjects [71], and importantly also in patients with cardiovascular disease [75].
However, further research is required to understand the potential benefit of exercise to
endothelial health in patients with subclinical cardiovascular disease characterized by
endothelial dysfunction secondary to comorbidities, including metabolic syndrome or in
patients subjected to the acute inflammatory insult of surgery.
Exercise has been shown to improve exercise capacity, specifically the anaerobic threshold (AT)
and the maximum oxygen consumption (pVO2), and underlying endothelial reserve. In
healthy subjects, Laufs et al. [76] showed that moderate and intense running for 30 min (80–
100% velocity of individuals’ AT) increased circulating EPC levels, but this was not seen with
running occurred at short intervals (10 minutes). In elderly patients with coronary artery
disease, a 4‐week exercise program achieved significant upregulation of circulating EPCs.
More recently, this was achieved after an even shorter (15 days) cardiac rehabilitation program,
with an increase in EPCs that correlated with improved exercise capacity [73]. Other markers
of improved endothelial function from a cardiac rehabilitation program included: a two‐fold
increase in EPCs, a three‐fold increase in CFU, increased blood nitrite concentration, and
reduced EPC apoptosis [75]. The duration and the intensity of exercise that are needed to
adequately stimulate EPC mobilization and improve endothelial function require further
investigation [77]. Surgical injury induces the mobilization of EPCs, with significantly higher
circulating EPC and bone marrow EPC levels observed 24 hours after surgery in an animal
model [78]. The ability to mount an EPC response is also seen in critical illness, and the response
is significantly greater in patients that survive sepsis [27], and recover from illness, for example,
without fibrotic changes after pneumonia [40].
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Given that “responders” who mount a “cellular” stress response to injury, with increased EPC
mobilization, have improved organ recovery [40] and improved survival [27], it is increasingly
clear that a bone marrow‐derived cellular component must follow the surgical “stress re‐
sponse” to facilitate repair processes. In a recent pilot study, we were able to demonstrate that
patients scheduled for major surgery that exhibited an EPC response to the stressor of
preoperative exhaustive exercise with a single cardiopulmonary exercise test up to pVO2
suffered significantly fewer postoperative complications [69]. Whether strategies to improve
bone marrow capacity and responsiveness will influence a patient’s ability to withstand
surgical injury remains to be investigated. Increasing this bone marrow‐derived regenerative
response through preoperative exercise training may be one potential therapeutic option to
optimize patients’ health status prior to surgery.
However, discovering an inadequate EPC response during acute illness, such as impaired
wound healing, pneumonia, acute lung injury [64], or sepsis [65], is likely too late. Hence, using
a surrogate stressor, for example, exercise, to allow for early identification of at‐risk patients
prior to surgery will enable timely strategies to improve bone marrow responsiveness to be
implemented. Importantly, some of the endothelial dysfunction, particularly that acquired in
the perioperative period, may be transient or reversible and may not actually involve structural
change in the cells of the vascular endothelium, but more likely potentially reversible altera‐
tions in function—so these would not require new cells, just repair of a damaged process.
Importantly, whether this lack of EPC response is an epiphenomenon, a surrogate marker, or
indeed causative of increased postoperative complications, requires further study. The
causative nature is supported by animal studies that suggest that exogenous EPC administra‐
tion can rescue endotoxin‐induced acute respiratory distress syndrome (ARDS), with reduced
inflammation, improved oxygenation, and improved survival [38, 39].
Jeong et al. [79], investigating whether diabetic neuropathy could be reversed by local
transplantation of EPCs, reported that motor and sensory nerve conduction velocities, blood
flow, and capillary density were reduced in sciatic nerves of streptozotocin‐induced diabetic
mice; with recovery after hindlimb injection of bone marrow‐derived EPCs that were shown
to engraft in close proximity to the vasa nervorum. This study demonstrated that bone marrow‐
derived EPCs could reverse manifestations of diabetic neuropathy, and that cell‐based
translational approaches may provide a novel and valid therapeutic alternative in the future.
Exercise [80] and tissue insult from surgery [78] are known to increase the mobilization of EPC.
In this manner, cardiopulmonary exercise testing (CPET) can be used as a catalyst to increase
the circulating population of EPCs and as a diagnostic tool of a patient’s ability to mount an
EPC response preoperatively. Additional gas exchange parameters obtained during a diag‐
nostic CPET (anaerobic threshold and peak VO2) can be used to determine patients’ individual
physiologic capacity and the amount of exercise needed in order to stimulate the population
of EPC. Preoperative exercise training could condition patients’ individual functional capacity
and to improve endothelial reserve by affecting EPC responsiveness. As such, Cesari et al. [73]
reported a significant increase in circulating EPCs in those patients that improved their exercise
capacity by more than 23%, as assessed by a six‐minute walk test, after completion of a
rehabilitation program.
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10. Exercise and inflammation
Regular exercise has been described to be involved in risk reduction of many chronic patho‐
logical alterations such as cancer, cardiovascular, and neurodegenerative diseases. One key
mechanism, which is frequently discussed in this context, is that exercise contributes to an
anti‐inflammatory environment, thereby counteracting a major risk factor of those diseases
[81–83]. This hypothesis is supported by a vast body of literature, indicating that acute exercise
induces a short‐term strong increase in the pro‐inflammatory cytokine interleukin‐6, which in
turn induces a long‐term depression of TNF‐α and the expression of anti‐inflammatory
mediators, such as interleukin‐10 and soluble receptors of interleukin‐1 [84]. Furthermore,
recent research suggests that regular exercise suppresses over a life‐span the permanent
expression of inflammatory cytokines via epigenetic mechanisms. Nakajima et al. [85] showed
that the DNA‐methylation in the promoter region of the ASC gene, the products of which
induce inflammation, is decreased in older subjects. An intermediate exercise intervention
resulted in a re‐methylation of this region; hence, the methylation pattern of 60‐ to70‐year old
was corrected to those of 30‐ to 40‐year‐old study participants.
The anti‐inflammatory effect of exercise is mediated by cells which secrete protective cytokines,
such as interleukin‐6, which is expressed by skeletal muscle‐tissue during physical activity.
However, little is known about the exact mechanism in which exercise triggers the anti‐
inflammatory component. Evidence rises that regular exercise and higher levels of cardiovas‐
cular fitness are related to an increased number of regulatory T‐cells. Since these cells have
strong anti‐inflammatory properties (e.g., by secreting Interleukin‐10), they may contribute to
the intermediate anti‐inflammatory effect of exercise [86].
Exercise is involved in multiple processes establishing an anti‐inflammatory environment,
which counteracts with perioperative inflammatory stress. Therefore, preoperative exercise,
which is feasible over a 1‐month time period, may contribute to a reduction of the inflammatory
burden that is present in patients undergoing surgery.
11. Other aspects of exercise promoting endothelium‐dependent vascular
function
Besides the mobilization of EPCs and its anti‐inflammatory properties, exercise is known to
regulate key factors of vascular functioning. Furthermore, exercise induces the expression of
the endothelial nitric oxide synthase (eNOS) and increases the levels of VEGF [87–89]. The first
studies revealed that the regulation of these factors is at least partially driven by epigenetic
mechanisms. Wu et al. [90] revealed that exercise in rats results in a downregulation of the
microRNA155. Interestingly, the messenger RNA of eNOS is known to be inhibited by
microRNA155. One essential mediator may be displayed by shear‐stress which is also
associated with epigenetic modifications of the chromatin (histone modifications) in the eNOS
gene region [91, 92]. Fernandes et al. [93] found reduced levels of microRNA126 and 16 in
exercising animals. Both microRNAs were previously described to inhibit the expression of
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VEGF. Although the previous studies give a premature insight into the underlying mechanism,
they display that exercise truly contributes to the improvement of vascular function and
regeneration on the molecular level. Further research, especially in humans, is warranted to
get more information about the mechanism and dose–response relationship of exercise
contributing to endothelial and vascular regeneration.
12. Conclusion/Summary
Impaired microcirculation secondary to underlying vascular endothelial dysfunction is
increasingly recognized to play a central role in the pathophysiology associated with numer‐
ous postoperative complications. Noxious stimuli, including direct injury from surgical
trauma and hypoxia (e.g., ischemia‐reperfusion injury), trigger adrenergic‐inflammatory‐
thrombotic‐immune cascades to impair the microcirculation, with consequent perfusion‐
related postoperative complications.
The endothelium, characterized by exquisite sensitivity to inflammation and low proliferative
potential, has limited self‐repair capacity that is dependent on circulating bone marrow‐
derived endothelial progenitor cells for regeneration. As such, the extent to which the endo‐
thelial physical and functional integrity and bone marrow responsiveness, for the circulating
progenitor pool, is preserved mirrors not only underlying cardiovascular health but also as an
important factor in susceptibility to postoperative morbidity.
This review explores the effect of perioperative inflammation on the microcirculation and some
of the current protective strategies available to clinicians. “Prehabilitation,” with preoperative
exercise to improve underlying endothelial function and bone marrow responsiveness for
endogenous endothelial repair mechanisms, and anti‐inflammatory strategies to limit activa‐
tion of the endothelial‐thrombotic‐inflammatory cascades may provide clinical strategies to
preserve the microcirculation to engender optimal surgical outcomes.
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